KASINGER JAMES R.

Insider CIK 1708172 · CRSP General Counsel and Secretary

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CRSP CRISPR Therapeutics AG	A Award deriv	2026-10-26	2026-10-28	9,000	—	$0	9,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2026-10-26	2026-10-28	18,000	—	$0	18,000	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-10-14	2026-10-15	1,040	$49.26	$51.2K	95,857	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-10-13	2026-10-15	2,113	—	—	0	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-10-13	2026-10-15	2,113	—	—	96,897	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-10-06	2026-10-08	1,990	—	$0	81,242	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-10-06	2026-10-08	1,990	$60.04	$119.5K	94,784	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-10-06	2026-10-08	1,990	$13.62	$27.1K	96,774	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-09-22	2026-09-24	10,400	—	$0	83,232	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-09-22	2026-09-24	10,400	$13.62	$141.6K	105,184	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-09-22	2026-09-24	10,400	$60.24	$626.5K	94,784	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-09-22	2026-09-24	10,400	—	$0	83,232	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-09-22	2026-09-24	10,400	$60.24	$626.5K	94,784	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-09-22	2026-09-24	10,400	$13.62	$141.6K	105,184	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2026-05-29	2026-06-02	17,000	—	$0	17,000	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-03-23	2026-03-24	3,182	$46.78	$148.9K	94,308	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2026-03-20	2026-03-24	25,000	—	$0	25,000	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-03-20	2026-03-24	6,250	—	$0	12,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2026-03-20	2026-03-24	38,499	—	$0	38,499	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-03-20	2026-03-24	6,250	—	$0	97,490	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-03-16	2026-03-17	3,450	$48.26	$166.5K	91,240	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-03-14	2026-03-17	6,875	—	$0	20,625	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-03-14	2026-03-17	6,875	—	$0	94,690	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-03-11	2026-03-12	2,800	$52.80	$147.8K	87,815	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-03-10	2026-03-12	5,500	—	$0	5,500	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-03-10	2026-03-12	5,500	—	$0	90,615	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2026-02-19	2026-02-20	2,112	$52.58	$111.0K	85,115	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2026-02-18	2026-02-20	3,825	—	$0	0	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2026-02-18	2026-02-20	3,825	—	$0	87,227	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2025-10-14	2025-10-15	1,076	$66.60	$71.7K	83,402	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2025-10-13	2025-10-15	2,114	—	$0	2,113	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2025-10-13	2025-10-15	2,114	—	$0	84,478	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2025-10-03	2025-10-03	16,500	—	$0	16,500	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2025-03-21	2025-03-24	3,185	$41.23	$131.3K	81,729	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2025-03-20	2025-03-24	6,250	—	$0	18,750	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2025-03-20	2025-03-24	6,250	—	$0	84,914	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2025-03-14	2025-03-18	27,500	—	$0	27,500	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2025-03-14	2025-03-18	36,666	—	$0	36,666	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2025-03-12	2025-03-12	1,116	$43.32	$48.3K	78,664	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2025-03-11	2025-03-12	2,250	—	$0	0	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2025-03-11	2025-03-12	2,250	—	$0	79,780	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2025-03-11	2025-03-12	2,850	$42.42	$120.9K	77,530	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2025-03-10	2025-03-12	5,500	—	$0	11,000	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2025-03-10	2025-03-12	5,500	—	$0	80,380	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2025-02-19	2025-02-19	1,947	$52.80	$102.8K	74,880	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2025-02-18	2025-02-19	3,825	—	$0	3,825	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2025-02-18	2025-02-19	9,595	$53.85	$516.7K	73,002	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2025-02-18	2025-02-19	3,825	—	$0	76,827	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2025-02-16	2025-02-19	20,000	—	$0	0	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2025-02-16	2025-02-19	20,000	—	$0	82,597	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2024-10-16	2024-10-18	30,000	—	$0	30,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2024-10-16	2024-10-18	18,333	—	$0	18,333	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2024-10-14	2024-10-15	1,089	$46.28	$50.4K	62,597	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2024-10-13	2024-10-15	2,113	—	$0	4,227	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2024-10-13	2024-10-15	2,113	—	$0	63,686	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2024-03-20	2024-03-22	25,000	—	$0	25,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2024-03-20	2024-03-22	33,333	—	$0	33,333	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2024-03-12	2024-03-12	1,146	$74.44	$85.3K	61,174	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2024-03-11	2024-03-12	2,250	—	$0	2,250	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2024-03-11	2024-03-12	2,801	$78.26	$219.2K	60,070	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2024-03-11	2024-03-12	2,250	—	$0	62,320	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2024-03-10	2024-03-12	5,500	—	$0	16,500	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2024-03-10	2024-03-12	5,500	—	$0	62,871	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2024-02-20	2024-02-21	1,913	$79.67	$152.4K	57,371	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2024-02-18	2024-02-21	3,825	—	$0	7,650	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2024-02-18	2024-02-21	3,825	—	$0	59,284	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2023-10-13	2023-10-17	6,340	—	$0	6,340	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2023-10-13	2023-10-17	16,667	—	$0	16,667	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2023-03-13	2023-03-14	1,283	$43.22	$55.5K	53,616	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2023-03-13	2023-03-14	1,022	$43.22	$44.2K	54,844	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2023-03-11	2023-03-14	2,250	—	$0	4,500	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2023-03-11	2023-03-14	2,250	—	$0	55,866	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2023-03-10	2023-03-14	2,833	—	$0	0	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2023-03-10	2023-03-14	22,000	—	$0	22,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2023-03-10	2023-03-14	40,000	—	$0	40,000	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2023-03-10	2023-03-14	2,833	—	$0	54,899	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2023-02-21	2023-02-22	1,950	$48.26	$94.1K	52,066	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2023-02-18	2023-02-22	3,825	—	$0	11,475	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2023-02-18	2023-02-22	3,825	—	$0	54,016	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2022-12-05	2022-12-06	3,234	$52.26	$169.0K	50,191	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2022-12-03	2022-12-06	6,667	—	$0	0	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2022-12-03	2022-12-06	6,667	—	$0	53,425	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2022-10-07	2022-10-12	14,000	—	$0	14,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2022-08-16	2022-08-18	20,000	—	$0	20,000	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2022-03-14	2022-03-14	1,039	$61.08	$63.5K	46,429	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2022-03-11	2022-03-14	2,250	—	$0	6,750	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2022-03-11	2022-03-14	1,321	$62.56	$82.6K	45,218	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2022-03-11	2022-03-14	2,250	—	$0	47,468	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2022-03-10	2022-03-14	2,834	—	$0	2,833	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2022-03-10	2022-03-14	2,834	—	$0	46,539	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2022-02-18	2022-02-22	34,200	—	$0	34,200	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2022-02-18	2022-02-22	15,300	—	$0	15,300	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2021-12-06	2021-12-07	6,303	$69.17	$436.0K	43,542	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2021-12-03	2021-12-07	13,333	—	$0	6,667	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2021-12-03	2021-12-07	13,333	—	$0	49,845	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2021-12-02	2021-12-03	7,342	—	$0	93,632	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2021-12-02	2021-12-03	7,342	$13.62	$100.0K	36,512	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2021-10-15	2021-10-18	10,800	—	$0	10,800	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2021-09-13	2021-09-14	4,741	$117.86	$558.8K	29,170	SEC↗
CRSP CRISPR Therapeutics AG	D To issuer deriv	2021-09-10	2021-09-14	10,000	—	$0	0	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2021-09-10	2021-09-14	10,000	—	$0	33,911	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2021-03-11	2021-03-12	9,000	—	$0	9,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2021-03-11	2021-03-12	25,360	—	$0	25,360	SEC↗
CRSP CRISPR Therapeutics AG	F Tax w/h	2021-03-10	2021-03-12	1,353	$124.15	$168.0K	23,911	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2021-03-10	2021-03-12	2,833	—	$0	25,264	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2021-01-19	2021-01-20	27,500	—	$0	12,500	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2021-01-19	2021-01-20	8,997	$205.60	$1.85M	26,331	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2021-01-19	2021-01-20	7,818	$204.40	$1.60M	35,328	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2021-01-19	2021-01-20	6,785	$203.58	$1.38M	43,146	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2021-01-19	2021-01-20	27,500	$51.49	$1.42M	49,931	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2021-01-19	2021-01-20	2,100	$207.61	$436.0K	22,431	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2021-01-19	2021-01-20	1,800	$206.05	$370.9K	24,531	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2020-12-09	2020-12-10	22,026	—	$0	100,974	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2020-12-09	2020-12-10	22,026	$13.62	$300.0K	22,415	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2020-10-05	2020-10-06	11,666	—	$0	11,666	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2020-03-10	2020-03-12	8,500	—	$0	8,500	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2020-03-10	2020-03-12	35,000	—	$0	35,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2019-12-03	2019-12-05	20,000	—	$0	20,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2019-09-10	2019-09-12	10,000	—	$0	10,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2019-03-05	2019-03-07	65,000	—	$0	65,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2018-06-15	2018-06-15	32,000	—	$0	32,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2018-03-07	2018-03-09	40,000	—	$0	40,000	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2017-05-31	2017-06-02	123,000	—	$0	123,000	SEC↗